Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.

Hilburg, Rachel; Geara, Abdallah S; Qiu, Maylene Kefeng; Palmer, Matthew B; Chiang, Elaine Y; Burger, Robert A; Hogan, Jonathan J

Bevacizumab-associated thrombotic microangiopathy treated with eculizumab: A case series and systematic review of the literature.

Hilburg, Rachel; Geara, Abdallah S; Qiu, Maylene Kefeng; Palmer, Matthew B; Chiang, Elaine Y; Burger, Robert A; Hogan, Jonathan J.

Clin Nephrol ; 96(1): 51-59, 2021 Jul.

Article in En | MEDLINE | ID: mdl-33896447

Subject(s)

Antibodies, Monoclonal, Humanized/adverse effects; Antineoplastic Agents, Immunological/adverse effects; Bevacizumab/adverse effects; Thrombotic Microangiopathies/chemically induced; Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Agents, Immunological/therapeutic use; Bevacizumab/therapeutic use; Humans; Neoplasms/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thrombotic Microangiopathies / Antibodies, Monoclonal, Humanized / Bevacizumab / Antineoplastic Agents, Immunological Type of study: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Journal: Clin Nephrol Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google